← Leaderboards
Fabio Romerio
Johns Hopkins University
$6,506,418
Attributed
$7,231,188
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $862.2K · FY2009–24$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,231,188 · 7
By mechanism
R01$5,085,608 · 2
R21$1,981,830 · 4
R03$163,750 · 1
Top collaborators
- Mathias Lichterfeld4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Justin Richard Bailey$16,021,335
- Andrea L Cox$41,369,991
- Robert F Siliciano$70,514,274
- Deborah Persaud$30,632,571
- Richard B. Markham$15,441,953
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionCd4 Positive T LymphocytesCellsHiv-1ProvirusesIn VivoInterruptionAntiretroviral TherapyIn VitroViralVirus ReplicationVirusPharmaceutical PreparationsNovel StrategiesVirionPeripheral BloodGenetic TranscriptionMemory Cd4 T LymphocyteDesignLifePublic Health RelevanceClinical PracticeImmunologicsGenes
Grant awards (19)
Sustained HIV Remission via Sequence-Specific Epigenetic Silencing of Latent Proviruses$636,701
R01 · FY2024 · AI · contact PI
Sustained HIV Remission via Sequence-Specific Epigenetic Silencing of Latent Proviruses$631,578
R01 · FY2023 · AI · contact PI
An inducible and cell specific transgenic mouse model to study the HIV-1 antisense protein ASP$81,875
R03 · FY2023 · AI · contact PI
An inducible and cell specific transgenic mouse model to study the HIV-1 antisense protein ASP$81,875
R03 · FY2022 · AI · contact PI
Sustained HIV Remission via Sequence-Specific Epigenetic Silencing of Latent Proviruses$678,151
R01 · FY2021 · AI · contact PI
Sustained HIV Remission via Sequence-Specific Epigenetic Silencing of Latent Proviruses$847,711
R01 · FY2020 · AI · contact PI
Sustained HIV Remission via Sequence-Specific Epigenetic Silencing of Latent Proviruses$841,926
R01 · FY2019 · AI · contact PI
Quantification of the HIV-1 Reservoir by Immuno-PCR$410,625
R01 · FY2018 · AI · contact PI
Defining the HLA ligandome of HIV-1 latently infected CD4 + T cells$193,125
R21 · FY2018 · AI · contact PI
Quantification of the HIV-1 Reservoir by Immuno-PCR$410,416
R01 · FY2017 · AI · contact PI
Defining the HLA ligandome of HIV-1 latently infected CD4 + T cells$231,750
R21 · FY2017 · AI · contact PI
PrimeFlow RNA for detection of latently-infected CD4+ T cells$220,015
R21 · FY2017 · AI · contact PI
Quantification of the HIV-1 Reservoir by Immuno-PCR$410,000
R01 · FY2016 · AI · contact PI
PrimeFlow RNA for detection of latently-infected CD4+ T cells$262,508
R21 · FY2016 · AI · contact PI
Quantification of the HIV-1 Reservoir by Immuno-PCR$218,500
R01 · FY2015 · AI · contact PI
Cell Surface Marker Combinations to Identify Latently Infected CD4+ Cells In Vivo$400,341
R21 · FY2014 · AI · contact PI
Cell Surface Marker Combinations to Identify Latently Infected CD4+ Cells In Vivo$252,962
R21 · FY2013 · AI · contact PI
A New Insight into HIV-1 Latency Through a Novel in Vitro System$191,836
R21 · FY2010 · AI · contact PI
A New Insight into HIV-1 Latency Through a Novel in Vitro System$229,293
R21 · FY2009 · AI · contact PI